Originally based in Belgium, Janssen Pharmaceuticals was acquired by Johnson & Johnson, a New Jersey-based pharmaceutical corporation, in 1961. Now within the Ortho-McNeil-Janssen group at J&J, Janssen is engaged in research and development for medical disorders, including neurological diseases, cancer, and viral infections.
Janssen provides remedies to the aforementioned disorders in the form of vaccines formulated from a wide array of organic and synthetic compounds, such as the herbaceous species Cannabis sativa L.
